ABI
ENDP

Adamant Biomedical Investments’s Endo International plc ENDP Stock Holding History

Adamant Biomedical Investments’s Portfolio ENDP Stock Details ENDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.88M Hold
40,000
– – 0.69% 50
2014
Q3 		$2.73M Buy
+40,000
New +$2.63M 0.68% 50

Other funds holding ENDP

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM

Adamant Biomedical Investments's ENDP Position: Q4 2014 in Review

Adamant Biomedical Investments held its Endo International plc (ENDP) position steady in Q4 2014 at 40,000 shares worth $2.88M. The position accounts for 0.69% of the portfolio, ranked #50.

Adamant Biomedical Investments first reported a position in ENDP in Q3 2014 and has held it in 2 quarters since. 302 funds tracked by Wall St. Rank hold ENDP as of Q4 2014.

  • Adamant Biomedical Investments held 40,000 shares of Endo International plc worth $2.88M as of Q4 2014.
  • Adamant Biomedical Investments left its Endo International plc share count unchanged in Q4 2014.
  • Endo International plc made up 0.69% of Adamant Biomedical Investments's portfolio in Q4 2014, its #50 holding.
  • Adamant Biomedical Investments first reported a position in Endo International plc in Q3 2014 and has held it in 2 quarters since.
  • 302 funds tracked by Wall St. Rank held Endo International plc as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.